LabGenomics.

At a glance

LabGenomics. filed 58 disclosures in the last 12 months, including 7 insider, 5 5% holder, 1 buyback and 1 issuance. The most recent key filing was on Oct 23: Plans to buy back 613,496 sh of treasury stock, Oct 26 to Jan 22.

Revenue for 2025 was ₩88.2B, up 2.6% on 2024. It made an operating loss of ₩53.5B. Debt was 54% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩33.7B and operating loss of ₩11B.

The 2025 annual report lists 142 employees with an average tenure of 3.2 years and average pay of ₩49.7M, #1740 of 2,191 listed companies by average pay. Its 7 directors and auditors were paid ₩40M each on average. It paid no cash dividend for 2025. 루하갈락티코스 유한회사 and related parties held 16.69% at year end.

Of 5 recent 5%+ holder reports, 3 raised and 2 cut a stake; the largest stake reported was 28.06% on Jul 14.

From the 2025 annual report

Staff: 142 (90 men, 52 women), of whom 7 on fixed-term contracts. Total pay for the year: ₩8.2B. Directors and auditors: 7, paid ₩283M in total.

No cash dividend was paid for 2025.

Largest shareholder

루하갈락티코스 유한회사 holds 16.16%; with 10 related parties the group holds 16.69% of common shares at year end.

Auditor: 삼덕회계법인 · opinion: Unqualified. The report includes an emphasis of matter.

Source: 2025 annual business report (DART). How figures are combined

Financial summary

5%+ holder reports